V-1 Immunitor: Phase II

In a placebo-controlled Thai Phase II trial in 35 HIV-negative volunteers, 20 volunteers given V-1 had a 28.2% and 17.5% increase in the number of CD4 and CD8 T cells, respectively, compared to no inc...